- Sonio is an AI-powered prenatal ultrasound reporting and practice management solution based in Boston, focused on enhancing the quality and efficiency of prenatal diagnostics.
- In March 2026, Sonio announced FDA clearance for the third version of Sonio Detect, which improves the automatic detection of ultrasound views and anatomical structures, and launched its reporting solution in the USA following a successful debut at SMFM 2024.
- Key customers include Pediatrix MFM Practice, and the company has established partnerships to enhance its offerings in prenatal diagnostics and education, such as the launch of soniopedia at FMF World Congress 2024.
- Sonio's ideal buyers are healthcare providers specializing in maternal-fetal medicine, as their solutions address the pain points of workflow efficiency and quality assurance in ultrasound diagnostics, making them a compelling choice for improving patient outcomes.
Sonio's workforce is structured across seven departments, with a notable concentration in Operations, which employs 8 individuals. The Sales and Information Technology departments each contribute 5 employees, reflecting a balanced focus on both client engagement and technical support. The Engineering, Media and Communications, and Marketing departments are smaller, with headcounts of 2, 1, and 1 respectively, while the 'Other' category encompasses 5 employees, indicating a diverse range of functions within the organization.
Sonio operates across four locations, with a significant presence in 'Other' locations accounting for 23 employees, suggesting a distributed workforce model. The top locations include La Palma, CA, Cambridge, MA, New York, NY, and Tampa, FL, each with a headcount of 1. This geographic distribution highlights a strategic approach to talent acquisition, allowing the company to leverage diverse markets while maintaining a centralized operational framework.
